Neoadjuvant 5-Fluorouracil, Epirubicin and Cyclophosphamide Chemotherapy Followed by Docetaxel in Refractory Patients With Locally Advanced Breast Cancer
Oncology Reports - Greece
doi 10.3892/or.17.1.253
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2007
Authors
Publisher
Spandidos Publications